Tech entrepreneur and biohacker Bryan Johnson has once again ignited debate in the longevity and medical science communities by claiming that he did not biologically age over the past year. Johnson, who has invested millions into his controversial “Blueprint” anti-aging protocol, now says his long-term goal is nothing short of “immortality by 2039.”
Johnson’s claim is based on a wide range of biomarkers, including epigenetic clocks, cardiovascular metrics, inflammation levels, and organ-specific health indicators. According to his team, these markers suggest that several of his organs are aging more slowly—or even reversing—compared to chronological expectations. However, experts caution that biological age is not a single, universally agreed-upon metric. Different tests often produce different results, and short-term stability in biomarkers does not necessarily equate to halted aging.
The deeper significance lies less in Johnson’s personal results and more in what his experiment represents. Blueprint is one of the most extreme examples of data-driven human optimization, involving strict dietary regimens, supplements, medical imaging, continuous monitoring, and experimental therapies. It reflects Silicon Valley’s broader belief that biology, like software, can be debugged, optimized, and eventually conquered.
Critics argue that such approaches risk oversimplifying aging, a complex process shaped by genetics, environment, and randomness. They also point out that Johnson’s protocol is prohibitively expensive and inaccessible to most people, raising ethical questions about longevity becoming a privilege of the wealthy.
Still, Johnson’s work is influencing mainstream science. Research into senolytics, epigenetic reprogramming, and AI-driven health monitoring is accelerating, with real potential to extend healthy lifespan—even if immortality remains elusive.
Ultimately, Johnson’s bold claim is less a declaration of scientific victory and more a provocation: forcing society to confront how far it is willing to go in the pursuit of radically longer life, and at what cost.
See What’s Next in Tech With the Fast Forward Newsletter
Tweets From @varindiamag
Nothing to see here - yet
When they Tweet, their Tweets will show up here.



